TG Therapeutics Inc (NASDAQ:TGTX)

23.68
Delayed Data
As of Jul 10
 -0.47 / -1.95%
Today’s Change
4.95
Today|||52-Week Range
24.76
+113.33%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 36.00, with a high estimate of 65.00 and a low estimate of 23.00. The median estimate represents a +52.03% increase from the last price of 23.68.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$22.8K
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 29.58%
 
 
 
 
 
 
Growthannually 19.81%
 
 
 
 
 
 

Sales

Growthquarterly -40.00%
 
 
 
 
 
 
Growthannually -22.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.